BUSINESS● LOW2h ago · Oct 9, 2026, 8:40 PM
CytoMed Therapeutics receives Nasdaq notice over minimum bid price deficiency
Seeking Alpha Tech · north america
CytoMed Therapeutics has received a notice from Nasdaq regarding a deficiency in its minimum bid price. This signifies that the company is not meeting certain listing requirements.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS41m agoBlack British Business Awards 2026 winners revealedThe TelegraphBUSINESS48m agoNCDMB pushes for greater access to assets to boost indigenous participation in energy sectorPremium Times